The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy

Brachytherapy

Volumn 9, Issue 3, 2010, Pages 213-218

  Piña, Alfonso Gómez Iturriaga ^a   Crook, Juanita Mary ^a   Kwan, Paul ^a   Borg, Jette ^a   Ma, Clement ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Perineural invasion; Permanent seed prostate brachytherapy; Prostate cancer

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER INVASION; CANCER SURVIVAL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERINEURAL INVASION; PERINEURIUM; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME;

EID: 77954952792     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.09.002     Document Type: Article

References (37)

1. Bonin S.R., Hanlon A.L., Lee W.R., et al. Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy. Cancer 1997, 79:75-80.
2. Villers A., McNeal J.E., Redwine E.A., et al. The role of perineural space invasion in the local spread of prostatic adenocarcinoma. J Urol 1989, 142:763-768.
3. Bastacky S.I., Walsh P.C., Epstein J.I. Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate. Am J Surg Pathol 1993, 17:336-341.
4. Stone N.N., Stock R.G., Parikh D., et al. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate. J Urol 1998, 160:1722-1726.
5. de la Taille A., Katz A., Bagiella E., et al. Perineural invasion on prostate needle biopsy: An independent predictor of final pathologic stage. Urology 1999, 54:1039-1043.
6. Rubin M.A., Mucci N.R., Manley S., et al. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: Can high grade tumor be predicted preoperatively?. J Urol 2001, 165:114-118.
7. Rubin M.A., Bassily N., Sanda M., et al. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. Am J Surg Pathol 2000, 24:183-189.
8. O'Malley K.J., Pound C.R., Walsh P.C., et al. Influence of biopsy perineural invasion on long-term biochemical disease-free survival after radical prostatectomy. Urology 2002, 59:85-90.
9. Ng J.C., Koch M.O., Daggy J.K., et al. Perineural invasion in radical prostatectomy specimens: Lack of prognostic significance. J Urol 2004, 172:2249-2251.
10. Miyake H., Sakai I., Harada K., et al. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Hinyokika Kiyo 2005, 51:241-246.
11. Cannon G.M., Pound C.R., Landsittel D.P., et al. Perineural invasion in prostate cancer biopsies is not associated with higher rates of positive surgical margins. Prostate 2005, 63:336-340.
12. Kestin L.L., Goldstein N.S., Vicini F.A., et al. Percentage of positive biopsy cores as predictor of clinical outcome in prostate cancer treated with radiotherapy. J Urol 2002, 168:1994-1999.
13. Beard C., Schultz D., Loffredo M., et al. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66:403-407.
14. Wong W.W., Schild S.E., Vora S.A., et al. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004, 60:24-29.
15. Grann A., Gaudin P.B., Raben A., et al. Pathologic features from prostate needle biopsy and prognosis after I-125 brachytherapy. Radiat Oncol Investig 1998, 6:170-174.
16. Merrick G.S., Butler W.M., Wallner K.E., et al. Prognostic significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy. Urology 2005, 66:1048-1053.
17. Weight C.J., Ciezki J.P., Reddy C.A., et al. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2006, 65:347-350.
18. Roach M., Hanks G., Thames H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO phoenix consensus conference. Int J Radiat Oncol Biol Phys 2006, 65:965-974.
19. Crook J., Gillan C., Yeung I., et al. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Int J Radiat Oncol Biol Phys 2007, 69:426-433.
20. Srigley J.R. Key issues in handling and reporting radical prostatectomy specimens. Arch Pathol Lab Med 2006, 130:303-317.
21. Epstein J.I., Amin M., Boccon-Gibod L., et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 2005, 216:34-63.
22. Lee I.H., Roberts R., Shah R.B., et al. Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer. Int J Radiat Oncol Biol Phys 2007, 68:1059-1064.
23. Vargas S.O., Jiroutek M., Welch W.R., et al. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol 1999, 111:223-228.
24. Frank S.J., Grimm P.D., Sylvester J.E., et al. Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the united states. Brachytherapy 2007, 6:2-8.
25. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (partin tables) for the new millennium. Urology 2001, 58:843-848.
26. Sohayda C., Kupelian P.A., Levin H.S., et al. Extent of extracapsular extension in localized prostate cancer. Urology 2000, 55:382-386.
27. Davis B.J., Pisansky T.M., Wilson T.M., et al. The radial distance of extraprostatic extension of prostate carcinoma: Implications for prostate brachytherapy. Cancer 1999, 85:2630-2637.
28. Merrick G.S., Butler W.M., Wallner K.E., et al. Extracapsular radiation dose distribution after permanent prostate brachytherapy. Am J Clin Oncol 2003, 26:e178-e189.
29. Merrick G.S., Butler W.M., Wallner K.E., et al. Dosimetry of an extracapsular anulus following permanent prostate brachytherapy. Am J Clin Oncol 2007, 30:228-233.
30. Prior S.L., Griffiths A.P., Baxter J.M., et al. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 2006, 27:945-950.
31. Lewis P.D., Fradley S.R., Griffiths A.P., et al. Mitochondrial DNA mutations in the parotid gland of cigarette smokers and non-smokers. Mutat Res 2002, 518:47-54.
32. Petros J.A., Baumann A.K., Ruiz-Pesini E., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 2005, 102:719-724.
33. Singh K.K., Desouki M.M., Franklin R.B., et al. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol Cancer 2006, 5:14.
34. Dakubo G.D., Parr R.L., Costello L.C., et al. Altered metabolism and mitochondrial genome in prostate cancer. J Clin Pathol 2006, 59:10-16.
35. Prueitt R.L., Yi M., Hudson R.S., et al. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008, 68:1152-1164.
36. Merrick G.S., Butler W.M., Galbreath R.W., et al. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy. Cancer J 2002, 8:79-80.
37. Liebig C., Ayala G., Wilks J.A., et al. Perineural invasion in cancer: A review of the literature. Cancer 2009, 115:3379-3391.